[Pathogenetic therapy of pulmonary tuberculosis in adolescents].
The paper presents the therapeutical results of 82 adolescents suffering from respiratory tuberculosis. During multi-modality therapy by using tuberculin, oliphen plus prednisolone there were clear-cut changes in immunological parameters, an increase in therapeutical efficiency and an average 3-month reduction in hospital stay.
Pavlova
M V
MV
D000284:Administration, Oral; D000293:Adolescent; D000904:Antibiotics, Antitubercular / Q000494:pharmacology / Q000627:therapeutic use*; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D010647:Phenyl Ethers; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use*; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects; D016896:Treatment Outcome; D014373:Tuberculin / Q000494:pharmacology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism
D000904:Antibiotics, Antitubercular; D000975:Antioxidants; D010647:Phenyl Ethers; D014373:Tuberculin; C085806:olifen; D011239:Prednisolone; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Patogeneticheskaia terapiia tuberkuleza organov dykhaniia u podrostkov.